Albuszies Gerd, Vogt Josef, Wachter Ulrich, Thiemermann Christoph, Leverve Xavier M, Weber Sandra, Georgieff Michael, Radermacher Peter, Barth Eberhard
Universitätsklinikum, Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Parkstrasse 11, 89073 Ulm, Germany.
Intensive Care Med. 2007 Jun;33(6):1094-101. doi: 10.1007/s00134-007-0638-7. Epub 2007 Apr 26.
To investigate the role of the inducible nitric oxide synthase activation-induced excess nitric oxide formation on the rate of hepatic glucose production during fully resuscitated murine septic shock.
Prospective, controlled, randomized animal study.
University animal research laboratory.
Male C57Bl/6 and B6.129P2-Nos2(tm1Lau)/J (iNOS-/-) mice.
Fifteen hours after cecal ligation and puncture, anesthetized, mechanically ventilated and instrumented mice (wild-type controls, n = 13; iNOS-/-, n = 12; wild-type mice receiving 5 mg.kg(-1) i.p. of the selective iNOS inhibitor GW274150 immediately after cecal ligation and puncture, n =8) received continuous i.v. hydroxyethylstarch and norepinephrine to achieve normotensive and hyperdynamic hemodynamics.
Measurements were recorded 18, 21 and 24 h after cecal ligation and puncture. Liver microcirculatory perfusion and capillary hemoglobin O2 saturation (laser Doppler flowmetry and remission spectrophotometry) were well maintained in all groups. Despite significantly lower norepinephrine doses required to achieve the hemodynamic targets, the rate of hepatic glucose production (gas chromatography--mass spectrometry measurements of tissue isotope enrichment during continuous i.v. 1,2,3,4,5,6-13C6-glucose infusion) at 24 h after cecal ligation and puncture was significantly higher in both iNOS-/- and GW274150-treated mice, which was concomitant with a significantly higher hepatic phosphoenolpyruvate carboxykinase activity (spectrophotometry) in these animals.
In normotensive, hyperdynamic septic shock, both pharmacologic and genetic deletion of the inducible nitric oxide synthase allowed maintenance of hepatic glucose production, most likely due to maintained activity of the key regulatory enzyme of gluconeogenesis, phosphoenolpyruvate carboxykinase.
探讨诱导型一氧化氮合酶激活诱导的过量一氧化氮生成在完全复苏的小鼠脓毒症休克期间对肝脏葡萄糖生成速率的作用。
前瞻性、对照、随机动物研究。
大学动物研究实验室。
雄性C57Bl/6和B6.129P2-Nos2(tm1Lau)/J(iNOS基因敲除)小鼠。
在盲肠结扎和穿刺15小时后,对麻醉、机械通气并安装仪器的小鼠(野生型对照组,n = 13;iNOS基因敲除组,n = 12;在盲肠结扎和穿刺后立即腹腔注射5 mg.kg(-1)选择性iNOS抑制剂GW274150的野生型小鼠,n = 8)持续静脉输注羟乙基淀粉和去甲肾上腺素,以实现血压正常和高动力血流动力学状态。
在盲肠结扎和穿刺后18、21和24小时进行测量记录。所有组的肝脏微循环灌注和毛细血管血红蛋白氧饱和度(激光多普勒血流仪和反射分光光度法)均保持良好。尽管达到血流动力学目标所需的去甲肾上腺素剂量显著降低,但在盲肠结扎和穿刺后24小时,iNOS基因敲除组和GW274150治疗组小鼠的肝脏葡萄糖生成速率(在持续静脉输注1,2,3,4,5,6-13C6-葡萄糖期间通过气相色谱-质谱法测量组织同位素富集)均显著更高,这与这些动物肝脏磷酸烯醇式丙酮酸羧激酶活性(分光光度法)显著升高相伴。
在血压正常、高动力的脓毒症休克中,诱导型一氧化氮合酶的药物性抑制和基因缺失均能维持肝脏葡萄糖生成,这很可能是由于糖异生关键调节酶磷酸烯醇式丙酮酸羧激酶的活性得以维持。